Webbplats analys takeda.com
Takeda Pharmaceuticals: Global Homepage
Genereras på Mars 04 2026 10:15 AM
Gammal statistik? UPDATERA !
Ställningen är 53/100
SEO Innehåll
Titel
Takeda Pharmaceuticals: Global Homepage
Längd : 39
Perfekt, din titel innehåller mellan 10 och 70 tecken.
Beskrivning
Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
Längd : 131
Bra, din metabeskrivning innehåller mellan 70 och 160 tecken.
Nyckelord
Mycket dåligt. Vi har inte lyckats hitta några meta-taggar på din sida. Använd denna meta-tag generator, gratis för att skapa nyckelord.
Og Meta Egenskaper
Bra, din sida drar nytta utav Og.
| Egendom | Innehåll |
|---|---|
| title | Takeda Pharmaceuticals: Global Homepage |
| description | Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future. |
| url | https://www.takeda.com/ |
| locale | en |
| image | http://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg |
| image:secure_url | https://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg |
| image:width | 1200 |
| image:height | 627 |
| image:type | image |
| image:alt | Takeda Pharmaceuticals: Global Homepage |
| type | website |
Rubriker
| H1 | H2 | H3 | H4 | H5 | H6 |
| 1 | 5 | 14 | 0 | 0 | 0 |
- [H1] Takeda Pharmaceuticals: Global Homepage
- [H2] Expanding access to hereditary angioedema care in Vietnam
- [H2] Recent News
- [H2] Better Health, Brighter Future
- [H2] Our Areas of Focus
- [H2] Sign up for investors newsletter
- [H3] Takeda - Global
- [H3] Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Rusfertide as a Potential First-in-Class Therapy for Polycythemia Vera
- [H3] Positive Phase 3 Data Demonstrate Potential for ENTYVIO® (vedolizumab) to Address Treatment Gap for Children and Adolescents with Moderate to Severe Ulcerative Colitis
- [H3] U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 1
- [H3] Takeda Reports Third-Quarter FY2025 Results – Updates Full Year Outlook to Reflect VYVANSE® Generics Impact, OPEX Discipline and FX Tailwind – Progressing Toward Three Transformative Launches Ahead
- [H3] Join Us
- [H3] Investors
- [H3] R&D
- [H3] Gastrointestinal and Inflammation
- [H3] Rare Diseases
- [H3] Plasma-Derived Therapies
- [H3] Oncology
- [H3] Neuroscience
- [H3] Vaccines
Bilder
Vi hittade 6 bilder på denna webbsida.
Bra, de flesta eller alla dina bilder innehåller alt-attribut
Text/HTML Ratio
Ratio : 2%
Denna sidas förhållande mellan text till HTML-kod är lägre än 15 procent, vilket innebär att din webbplats troligen behöver mer textinnehåll.
Flash
Perfekt, inga Flash-innehåll har upptäckts på denna sida.
Iframe
Bra, vi upptäckte inga Iframes på den här sidan.
SEO Länkar
URL Rewrite
Bra. Dina adressfält ser bra ut!
Understreck i URLen
Perfekt! Inga understreck upptäcktes i din webbadress.
In-page länkar
Vi hittade totalt 134 länkar inklusive 0 länk(ar) till filer
| Anchor | Typ | Juice |
|---|---|---|
| Our Company | Interna | Passing Juice |
| Leadership | Interna | Passing Juice |
| Sustainability Approach | Interna | Passing Juice |
| Access to Medicines | Interna | Passing Juice |
| Sustainability Disclosures | Interna | Passing Juice |
| Ethics | Interna | Passing Juice |
| Transparency Disclosures | Interna | Passing Juice |
| Positions | Interna | Passing Juice |
| Corporate Giving | Interna | Passing Juice |
| Governance Strategy | Interna | Passing Juice |
| Governance Structure | Interna | Passing Juice |
| Charters and Reports | Interna | Passing Juice |
| Areas of Focus | Interna | Passing Juice |
| Research and Development | Interna | Passing Juice |
| Pipeline | Interna | Passing Juice |
| Our Products | Interna | Passing Juice |
| Manufacturing | Interna | Passing Juice |
| Suppliers | Interna | Passing Juice |
| Clinical Trials | Interna | Passing Juice |
| Our Stories | Interna | Passing Juice |
| Press Releases | Interna | Passing Juice |
| Statements | Interna | Passing Juice |
| Media Resources | Interna | Passing Juice |
| Overview | Interna | Passing Juice |
| Financial Results | Interna | Passing Juice |
| Investor Events | Interna | Passing Juice |
| Investor Contact | Interna | Passing Juice |
| Careers | Interna | Passing Juice |
| Leadership | Interna | Passing Juice |
| Sustainability Approach | Interna | Passing Juice |
| Access to Medicines | Interna | Passing Juice |
| Ethics | Interna | Passing Juice |
| Corporate Giving | Interna | Passing Juice |
| Governance Structure | Interna | Passing Juice |
| Charters and Reports | Interna | Passing Juice |
| Research and Development | Interna | Passing Juice |
| Pipeline | Interna | Passing Juice |
| Our Products | Interna | Passing Juice |
| Manufacturing | Interna | Passing Juice |
| Suppliers | Interna | Passing Juice |
| Clinical Trials | Interna | Passing Juice |
| Press Releases | Interna | Passing Juice |
| Statements | Interna | Passing Juice |
| Media Resources | Interna | Passing Juice |
| Overview | Interna | Passing Juice |
| Financial Results | Interna | Passing Juice |
| Investor Events | Interna | Passing Juice |
| Investor Contact | Interna | Passing Juice |
| English | Interna | Passing Juice |
| Japanese | Interna | Passing Juice |
| English | Interna | Passing Juice |
| French | Interna | Passing Juice |
| Arabic | Interna | Passing Juice |
| Spanish | Interna | Passing Juice |
| English | Interna | Passing Juice |
| German | Interna | Passing Juice |
| Russian | Interna | Passing Juice |
| English | Interna | Passing Juice |
| French | Interna | Passing Juice |
| Dutch | Interna | Passing Juice |
| Bosnian | Interna | Passing Juice |
| Portuguese | Interna | Passing Juice |
| Bulgarian | Interna | Passing Juice |
| English | Interna | Passing Juice |
| French | Interna | Passing Juice |
| Spanish | Interna | Passing Juice |
| Chinese | Interna | Passing Juice |
| Spanish | Interna | Passing Juice |
| Croatian | Interna | Passing Juice |
| Czech | Interna | Passing Juice |
| Danish | Interna | Passing Juice |
| Spanish | Interna | Passing Juice |
| English | Interna | Passing Juice |
| Arabic | Interna | Passing Juice |
| Estonian | Interna | Passing Juice |
| Finnish | Interna | Passing Juice |
| French | Interna | Passing Juice |
| German | Interna | Passing Juice |
| Greek | Interna | Passing Juice |
| English | Interna | Passing Juice |
| Chinese | Interna | Passing Juice |
| Hungarian | Interna | Passing Juice |
| English | Interna | Passing Juice |
| Indonesian | Interna | Passing Juice |
| English | Interna | Passing Juice |
| Hebrew | Interna | Passing Juice |
| Italian | Interna | Passing Juice |
| Kazakh | Interna | Passing Juice |
| Russian | Interna | Passing Juice |
| Korean | Interna | Passing Juice |
| Latvian | Interna | Passing Juice |
| Lithuanian | Interna | Passing Juice |
| English | Interna | Passing Juice |
| Spanish | Interna | Passing Juice |
| Dutch | Interna | Passing Juice |
| English | Interna | Passing Juice |
| Norweigan | Interna | Passing Juice |
| Spanish | Interna | Passing Juice |
| English | Interna | Passing Juice |
| Polish | Interna | Passing Juice |
| Portuguese | Interna | Passing Juice |
| Romanian | Interna | Passing Juice |
| Russian | Interna | Passing Juice |
| English | Interna | Passing Juice |
| Arabic | Interna | Passing Juice |
| Serbian | Interna | Passing Juice |
| English | Interna | Passing Juice |
| Slovak | Interna | Passing Juice |
| Slovenian | Interna | Passing Juice |
| English | Interna | Passing Juice |
| Spanish | Interna | Passing Juice |
| Swedish | Interna | Passing Juice |
| German | Interna | Passing Juice |
| French | Interna | Passing Juice |
| Chinese | Interna | Passing Juice |
| Thai | Interna | Passing Juice |
| Turkish | Interna | Passing Juice |
| Ukrainian | Interna | Passing Juice |
| English | Interna | Passing Juice |
| Arabic | Interna | Passing Juice |
| English | Interna | Passing Juice |
| English | Interna | Passing Juice |
| English | Interna | Passing Juice |
| - | Interna | Passing Juice |
| Locations | Interna | Passing Juice |
| Contact us | Interna | Passing Juice |
| Careers | Interna | Passing Juice |
| Financial Highlights | Interna | Passing Juice |
| HCPs | Interna | Passing Juice |
| Patients | Interna | Passing Juice |
| Terms and Conditions | Interna | Passing Juice |
| Privacy Notice | Interna | Passing Juice |
| Cookie Policy | Interna | Passing Juice |
| Accessibility Statement | Interna | Passing Juice |
SEO Nyckelord
Nyckelord Moln
takeda spanish english french patients arabic drug diseases corporate more
Nyckelord Konsistens
| Nyckelord | Innehåll | Titel | Nyckelord | Beskrivning | Rubriker |
|---|---|---|---|---|---|
| english | 38 |  |
|
|
|
| spanish | 14 | |
|
|
|
| diseases | 11 | |
|
|
 |
| french | 10 | |
|
|
|
| takeda | 9 | |
|
|
|
Användbarhet
Url
Domän : takeda.com
Längd : 10
Favikon
Bra, din webbplats har en favicon.
Utskriftbart
Vi kunde inte hitta CSS för utskrifter.
Språk
Bra. Ditt angivna språk är en.
Dublin Core
Denna sida drar inte nytta utav Dublin Core.
Dokument
Doctype
HTML 5
Encoding
Perfekt. Din deklarerade teckenuppsättning är UTF-8.
W3C Validity
Errors : 0
Varningar : 0
E-post Sekretess
Varning! Minst en e-postadress har påträffats i klartext. Använd gratis antispam skydd för att dölja e-post från spammare.
Föråldrad HTML
Bra! Vi har inte hittat några föråldrad HTML taggar i din HTML.
Hastighets Tips
|
Utmärkt, din webbplats använder inga nästlade tabeller. |
|
Synd, din webbplats använder sig utav inline stilar. |
|
Synd, din webbplats har för många CSS-filer (fler än 4 stycken). |
|
Synd, din webbplats har för många JS filer (fler än 6 stycken). |
|
Perfekt, din webbplats utnyttjar gzip. |
Mobil
Mobiloptimering
|
Apple Ikon |
|
Meta Viewport Tagg |
|
Flash innehåll |
Optimering
XML Sitemap
Bra, din webbplats har en XML sitemap.
| https://www.takeda.com/sitemap.xml |
Robots.txt
https://takeda.com/robots.txt
Bra, din webbplats har en robots.txt fil.
Analytics
Saknas
Vi hittade inte någon analysverktyg på din webbplats.
Webbanalys program kan mäta besökare på din webbplats. Du bör ha minst ett analysverktyg installerat, men det kan också vara en bra ide att installera två för att dubbelkolla uppgifterna.
PageSpeed Insights
Enhet
Kategorier
Free SEO Testing Tool
Free SEO Testing Tool är en fri SEO verktyg som hjälper dig att analysera din webbplats